Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 May 2024 – 20 Aug 2026, limited by Bandhan Innovation Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bandhan Innovation Fund | Nifty 500 |
|---|---|---|
| 02 May 2024 | ₹100.00 | ₹100.00 |
| 11 Jul 2024 | ₹113.81 | ₹109.11 |
| 19 Sep 2024 | ₹124.82 | ₹113.14 |
| 28 Nov 2024 | ₹123.91 | ₹106.79 |
| 06 Feb 2025 | ₹119.06 | ₹102.79 |
| 17 Apr 2025 | ₹114.99 | ₹102.84 |
| 26 Jun 2025 | ₹125.78 | ₹111.54 |
| 04 Sep 2025 | ₹129.54 | ₹108.23 |
| 13 Nov 2025 | ₹133.88 | ₹112.96 |
| 22 Jan 2026 | ₹125.40 | ₹109.13 |
| 02 Apr 2026 | ₹118.33 | ₹99.31 |
| 11 Jun 2026 | ₹132.54 | ₹104.89 |
| 20 Aug 2026 | ₹155.44 | ₹111.52 |
| Metric | Bandhan · Regular NAV ₹15.64 Very High risk ★★★★☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +19.74% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +21.14% | +12.26% | |
| +21.01% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 17.11% | 15.62% | |
| 0.77 | 0.43 | |
| 1.06 | 0.59 | |
| -19.88% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 2.25% | 2.39% | |
| ₹2,151Cr | ₹1,161Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 83% | 45% | |
| Brijesh Shah | — | |
| 02 May 2024 | — | |
| 80 | — | |
| 31.8% | — | |
| 1.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.